概要
Encoded Therapeutics is a clinical stage biotech developing precision genetic medicines through a proprietary vector engineering platform that enables cell type selective gene expression control in the brain and peripheral nervous system. Its lead program ETX101 is an AAV gene therapy for SCN1A-positive Dravet syndrome.
資金調達
| ラウンド |
金額 |
発表日 |
投資家 |
|
Series E+
|
会員限定 |
会員限定 |
投資家 12社 |